Niagen Bioscience Inc Reports Q3 2026 Loss of $(0.01) Per Share and Revenue of $27. ...
Net loss per share of $(0.01) compared with analyst estimates of $0.02; cash position strengthens to $69.5 million Related Stocks: NAGE ,
Net loss per share of $(0.01) compared with analyst estimates of $0.02; cash position strengthens to $69.5 million Related Stocks: NAGE ,